Value Sense
CLOV
Clover Health Investments, Corp. (CLOV)
Last Price$3.4(0.9%)
Market Cap$1,625.6M
LTM Capital Expenditure
($1,556.0K)
YoY Growth
+166.4%
3Y CAGR
+29.1%
5Y CAGR
+132.3%
Stock quality & Intrinsic value
5/10
46.9% overvalued
CLOV
is (46.9%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Clover Health Investments, Corp. Capital Expenditure

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Capital Expenditure
($1,476.0K)
($23.0K)
($693.0K)
($723.0K)
($4,467.0K)
($584.0K)
($1,556.0K)
CLOV
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CLOV and see if it's the right time to invest.
Dive in

Clover Health Investments, Corp. (CLOV) Capital Expenditure comparison analysis

General

LTM Capital Expenditure

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
($1,556.0K)
166.4%
29.1%
132.3%
Median Peer Set
($609.5M)
(5.7%)
4.1%
1.3%
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
($2,626.0K)
(90.4%)
(26.0%)
N/A
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
($27.9M)
9.1%
2.5%
N/A
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
($41.4M)
15.1%
31.2%
N/A
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
($100.0M)
19.0%
9.1%
11.9%
Humana Inc. logo
Humana Inc.HUM
($575.0M)
(42.7%)
(24.1%)
(4.8%)
Centene Corporation logo
Centene CorporationCNC
($644.0M)
(19.4%)
(10.9%)
(2.5%)
Elevance Health Inc. logo
Elevance Health Inc.ELV
($1,256.0M)
(3.1%)
4.9%
3.1%
Cigna Corporation logo
Cigna CorporationCI
($1,406.0M)
(10.6%)
6.8%
6.0%
CVS Health Corporation logo
CVS Health CorporationCVS
($2,781.0M)
(8.2%)
3.3%
2.5%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
($3,499.0M)
3.3%
12.6%
11.1%

CLOV key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
281.0
0.0%
462.3
64.5%
672.9
45.6%
1,472.0
118.8%
1,096.6
(25.5%)
1,260.5
15.0%
1,371.1
8.8%
Cost of Goods Sold (COGS)0.0449.7590.11,551.2993.11,004.61,006.3
Gross Profit
% margin
281.0
100.0%
12.6
2.7%
82.8
12.3%
(79.2)
(5.4%)
103.5
9.4%
256.0
20.3%
364.8
26.6%
Operating Expenses476.0195.8175.5557.8390.1461.3410.6
Research & Development Expenses (R&D)0.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)187.3187.3192.1445.7482.4440.2408.9
Operating Income
% margin
(185.8)
(66.1%)
(183.2)
(39.6%)
(92.7)
(13.8%)
(637.0)
(43.3%)
(286.7)
(26.1%)
(205.3)
(16.3%)
(45.7)
(3.3%)
Interest Income7.00.00.10.00.00.00.0
Interest Expense0.039.157.116.91.40.00.0
Pre-tax Income(201.9)(363.7)(136.4)(587.8)(254.6)(210.1)(46.3)
Income Tax
% effective tax rate
(16.1)
8.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
Net Income
% margin
(201.9)
(71.9%)
(363.7)
(78.7%)
(136.4)
(20.3%)
(587.8)
(39.9%)
(339.6)
(31.0%)
(213.4)
(16.9%)
(43.0)
(3.1%)
EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
Diluted EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
EBITDA
% margin
(16.1)
(5.7%)
(324.1)
(70.1%)
(78.7)
(11.7%)
(569.6)
(38.7%)
(252.0)
(23.0%)
(207.6)
(16.5%)
(44.9)
(3.3%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Clover Health Investments, Corp.'s Capital Expenditure?

As of today, Clover Health Investments, Corp.'s last 12-month Capital Expenditure is ($1,556.0K), based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is Clover Health Investments, Corp.'s Capital Expenditure growth rate?

Over the last year, Clover Health Investments, Corp.'s Capital Expenditure growth was 166.4%. The average annual Capital Expenditure growth rates for Clover Health Investments, Corp. have been 44.1% over the past three years, 132.3% over the past five years.

3) Is Clover Health Investments, Corp.'s Capital Expenditure growth rate Good?

Over the last year, Clover Health Investments, Corp.'s Capital Expenditure growth was 166.4%, which is higher than industry growth of (0.2%). It indicates that Clover Health Investments, Corp.'s Capital Expenditure growth is Bad.

4) How does Clover Health Investments, Corp.'s Capital Expenditure growth rate compare to its peers?

Over the last year, Clover Health Investments, Corp.'s Capital Expenditure growth was 166.4%, which is higher than peer median growth of (32.4%). The list of peers includes BHG, OSCR, ALHC, MOH, HUM, CNC, ELV, CI, CVS, UNH etc.